Ronald W. Penczek - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
CAO & Controller
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 17:00:06 UTC
Previous filing
11 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Penczek Ronald W CAO & Controller 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 04 Mar 2026 0001659075

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -131 -7% $294.07* 1,743 02 Mar 2026 Direct F1, F2
transaction ELV Common Stock Award +426 +24% $0.000000* 2,169 02 Mar 2026 Direct F3
transaction ELV Common Stock Award +1,701 +78% $0.000000* 3,870 02 Mar 2026 Direct F4
transaction ELV Common Stock Award +266 +6.9% $0.000000* 4,136 02 Mar 2026 Direct F5
transaction ELV Common Stock Tax liability -37 -0.89% $284.03* 4,099 03 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award +1,677 $0.000000* 1,677 02 Mar 2026 Common Stock 1,677 $294.07 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan.
F3 Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
F4 Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028.
F5 Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
F6 The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.